Affineo

Affineo was born out of a specific ambition: to facilitate the engineering of ultra-stable proteins.
Founded in November 2025 and supported by the Shaker and Gene.iO programs, it is based on an original screening technology developed entirely in-house.

Description of products / Services / Technologies

Affineo unlocks the full potential of all proteins. By pushing the limits of their stability, we make them more resistant, more effective, and more durable.
Our high-throughput in vivo screening identifies and validates candidates at a fraction of the cost of traditional approaches.

Affineo is poised to redefine the standards of protein engineering for food, health, and industry.

Achievements/Collaboration/Highlights

We demonstrated the robustness of our technology right from the initial tests. We have also assembled a network of experts who drive our innovation.
Today, we are turning our vision into reality by developing our first high-impact products.

Partnerships sought

Nous cultivons des collaborations ambitieuses avec des experts en protein design, IA et mutagénèse dirigée. Nous consolidons notre réseau de partenaires stratégiques avec des acteurs clés de l’alimentation, de la santé et de l’industrie.